Page last updated: 2024-08-24

isothiocyanic acid and Pulmonary Disease, Chronic Obstructive

isothiocyanic acid has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chen, Y; Dai, TT; Han, ZL; Li, CH; Song, QQ; Sun, NX; Wang, DL; Zhu, WT1
Bao, H; Liu, X; Zeng, X1

Other Studies

2 other study(ies) available for isothiocyanic acid and Pulmonary Disease, Chronic Obstructive

ArticleYear
Effect of allyl isothiocyanate on oxidative stress in COPD via the AhR / CYP1A1 and Nrf2 / NQO1 pathways and the underlying mechanism.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 114

    Topics: Animals; Antioxidants; Cytochrome P-450 CYP1A1; Humans; Isothiocyanates; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Rats; Signal Transduction

2023
Sulforaphane suppresses lipopolysaccharide- and Pam3CysSerLys4-mediated inflammation in chronic obstructive pulmonary disease via toll-like receptors.
    FEBS open bio, 2021, Volume: 11, Issue:5

    Topics: Aged; Anti-Inflammatory Agents; China; Female; Humans; Inflammation; Inflammation Mediators; Isothiocyanates; Lipopolysaccharides; Lipoproteins; Macrophages; Male; Middle Aged; Myeloid Differentiation Factor 88; Pulmonary Disease, Chronic Obstructive; Signal Transduction; Sulfoxides; Toll-Like Receptors; Tumor Necrosis Factor-alpha

2021